Telix Pharmaceuticals Limited’s Dividend Payout Ratio at a glance
Telix Pharmaceuticals Limited reports dividend payout ratio of 0% for Dec 2024. The prior period recorded 0% (Dec 2023). Year over year the metric moved +0 pts. The rolling three-period average stands at 0%. Data last refreshed Dec 7, 2025, 4:58 AM.
Latest reading
0% · Dec 2024
YoY movement
+0 pts
Rolling average
0%
Current Dividend Payout Ratio
0%
+0 pts
–
Rolling average
0%
Latest Value
0%
Dec 2024
YoY Change
+0 pts
Absolute
YoY Change %
–
Rate of change
3-Period Avg
0%
Smoothed
Narrative signal
Telix Pharmaceuticals Limited’s dividend payout ratio stands at 0% for Dec 2024. Year-over-year, the metric shifted by +0 pts, translating into a – rate of change versus the prior period.
Pair this momentum with product cadence, pricing power, and capital allocation moves to understand durability.
Blend with balance sheet, cash flow, and peer benchmarks from AlphaPilot’s broader dashboards to shape an investable thesis.
How dividend payout ratio shapes Telix Pharmaceuticals Limited's story
As of Dec 2024, Telix Pharmaceuticals Limited reports dividend payout ratio of 0%. Monitor dividend payout ratios to assess the sustainability of shareholder distributions and identify reinvestment priorities.
Reading payout discipline
Consistent payout ratios signal predictable dividend policy, while sharp swings can foreshadow changes in cash allocation.
Use with free cash flow
Compare payout ratios with free cash flow coverage to judge whether dividends are funded by operations or leverage.
Valuation Multiples
Compare how the market prices revenue, equity, and operating cash flow versus peers and history.
Profitability & Margins
Understand cost structure and capital efficiency trends across gross, operating, and net results.
Gross Margin
65.1%
Operating Margin
10.5%
Net Profit Margin
6.4%
Return on Equity
8.8%
Return on Assets
3.3%
Growth Momentum
Track whether top-line, earnings, and free cash flow growth are accelerating or cooling.
Balance Sheet Strength
Evaluate leverage, liquidity, and cash generation capacity that underpin resilience.
Shareholder Returns
Follow dividend sustainability and cash generation relative to market value.
Telix Pharmaceuticals Limited (TLX) FAQs
Answers tailored to Telix Pharmaceuticals Limited’s dividend payout ratio profile using the latest Financial Modeling Prep data.
What is Telix Pharmaceuticals Limited's current dividend payout ratio?
As of Dec 2024, Telix Pharmaceuticals Limited reports dividend payout ratio of 0%. This reading reflects the latest filings and price data for TLX.
How is Telix Pharmaceuticals Limited's dividend payout ratio trending year over year?
Year-over-year, the figure shifts by +0 pts. Pair this context with revenue growth and free cash flow signals to gauge momentum for TLX.
Why does dividend payout ratio matter for Telix Pharmaceuticals Limited?
Dividend payout ratio shows the share of earnings distributed as dividends. For Telix Pharmaceuticals Limited, operating within Healthcare — Biotechnology, tracking this metric helps benchmark management's execution against close competitors.
Is Telix Pharmaceuticals Limited's dividend payout ratio above its recent average?
Telix Pharmaceuticals Limited's rolling three-period average sits at 0%. Comparing the latest reading of 0% to that baseline highlights whether momentum is building or fading for TLX.
How frequently is Telix Pharmaceuticals Limited's dividend payout ratio refreshed?
Data for TLX was last refreshed on Dec 7, 2025, 4:58 AM and updates automatically every 24 hours, keeping your valuation inputs current.